$IART
Integra Lifesciences Holdings Corp

2017 Q1 Form 10-Q Financial Statement

#000091752017000023 Filed on April 26, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $258.6M $236.8M
YoY Change 9.24% 16.9%
Cost Of Revenue $86.59M $84.77M
YoY Change 2.14% 12.7%
Gross Profit $172.1M $152.0M
YoY Change 13.19% 19.39%
Gross Profit Margin 66.52% 64.2%
Selling, General & Admin $142.5M $112.0M
YoY Change 27.26% 20.06%
% of Gross Profit 82.82% 73.67%
Research & Development $15.49M $14.45M
YoY Change 7.22% 30.44%
% of Gross Profit 9.01% 9.51%
Depreciation & Amortization $19.72M $18.25M
YoY Change 8.02% 54.69%
% of Gross Profit 11.46% 12.01%
Operating Expenses $158.0M $126.4M
YoY Change 24.97% 21.16%
Operating Profit $9.959M $22.10M
YoY Change -54.94% 4.05%
Interest Expense $5.131M $6.373M
YoY Change -19.49% 16.47%
% of Operating Profit 51.52% 28.84%
Other Income/Expense, Net -$90.00K -$738.0K
YoY Change -87.8% -136.59%
Pretax Income $4.745M $15.00M
YoY Change -68.36% -15.71%
Income Tax -$1.649M $1.576M
% Of Pretax Income -34.75% 10.51%
Net Earnings $6.394M $13.42M
YoY Change -52.35% 60.05%
Net Earnings / Revenue 2.47% 5.67%
Basic Earnings Per Share $0.09 $0.18
Diluted Earnings Per Share $0.08 $0.18
COMMON SHARES
Basic Shares Outstanding 74.77M shares 73.93M shares
Diluted Shares Outstanding 78.39M shares 76.47M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $135.4M $77.10M
YoY Change 75.62% -3.5%
Cash & Equivalents $124.1M $77.09M
Short-Term Investments $11.30M
Other Short-Term Assets $35.50M $43.90M
YoY Change -19.13% -46.66%
Inventory $239.8M $222.0M
Prepaid Expenses
Receivables $158.2M $151.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $568.9M $494.6M
YoY Change 15.03% -5.25%
LONG-TERM ASSETS
Property, Plant & Equipment $229.1M $210.3M
YoY Change 8.93% 0.1%
Goodwill $578.2M $516.1M
YoY Change 12.04% 45.71%
Intangibles $654.4M $594.9M
YoY Change 10.01% 32.95%
Long-Term Investments
YoY Change
Other Assets $13.59M $7.280M
YoY Change 86.7% -36.34%
Total Long-Term Assets $1.480B $1.336B
YoY Change 10.81% 29.82%
TOTAL ASSETS
Total Short-Term Assets $568.9M $494.6M
Total Long-Term Assets $1.480B $1.336B
Total Assets $2.049B $1.830B
YoY Change 11.95% 18.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.60M $54.00M
YoY Change -15.56% 26.76%
Accrued Expenses $46.35M $44.84M
YoY Change 3.38% 9.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.300M $17.80M
YoY Change -64.61% 217.86%
Total Short-Term Liabilities $188.1M $156.6M
YoY Change 20.08% 23.52%
LONG-TERM LIABILITIES
Long-Term Debt $848.8M $712.2M
YoY Change 19.18% 16.49%
Other Long-Term Liabilities $28.86M $28.61M
YoY Change 0.87% -10.73%
Total Long-Term Liabilities $28.86M $28.61M
YoY Change 0.87% -10.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $188.1M $156.6M
Total Long-Term Liabilities $28.86M $28.61M
Total Liabilities $1.197B $1.054B
YoY Change 13.54% 22.16%
SHAREHOLDERS EQUITY
Retained Earnings $226.8M $157.6M
YoY Change 43.97% -51.27%
Common Stock $800.2M $1.023B
YoY Change -21.75% 31.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $123.1M $367.1M
YoY Change -66.48% 0.0%
Treasury Stock Shares 2.946M shares 8.915M shares
Shareholders Equity $852.5M $776.4M
YoY Change
Total Liabilities & Shareholders Equity $2.049B $1.830B
YoY Change 11.95% 18.02%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $6.394M $13.42M
YoY Change -52.35% 60.05%
Depreciation, Depletion And Amortization $19.72M $18.25M
YoY Change 8.02% 54.69%
Cash From Operating Activities $28.88M $25.03M
YoY Change 15.39% -20.84%
INVESTING ACTIVITIES
Capital Expenditures $9.191M $10.90M
YoY Change -15.64% 104.41%
Acquisitions $193.9M $0.00
YoY Change
Other Investing Activities -$184.0M $4.200M
YoY Change -4480.95% 27.27%
Cash From Investing Activities -$193.1M -$6.730M
YoY Change 2769.88% 19.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $185.0M $9.952M
YoY Change 1759.31% -171.98%
NET CHANGE
Cash From Operating Activities $28.88M $25.03M
Cash From Investing Activities -$193.1M -$6.730M
Cash From Financing Activities $185.0M $9.952M
Net Change In Cash $20.78M $28.25M
YoY Change -26.45% 132.32%
FREE CASH FLOW
Cash From Operating Activities $28.88M $25.03M
Capital Expenditures $9.191M $10.90M
Free Cash Flow $19.69M $14.14M
YoY Change 39.31% -46.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000917520
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75620857 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
INTEGRA LIFESCIENCES HOLDINGS CORP
CY2017Q1 dei Trading Symbol
TradingSymbol
iart
CY2016Q4 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
1871000 USD
CY2017Q1 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
2479000 USD
CY2016Q4 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
768333000 USD
CY2017Q1 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
873014000 USD
CY2016Q4 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
561175000 USD
CY2017Q1 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
654408000 USD
CY2017Q1 iart Finite Lived Intangible Assets Amortizationexpense Year Six
FiniteLivedIntangibleAssetsAmortizationexpenseYearSix
44200000 USD
CY2017Q1 iart Reduction In Notional Amount Of Interest Rate Derivatives In Next Twelve Months
ReductionInNotionalAmountOfInterestRateDerivativesInNextTwelveMonths
0 USD
CY2017Q1 iart Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
2 plan
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
29057000 USD
CY2017Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
45594000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
148186000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
158234000 USD
CY2016Q1 us-gaap Accretion Expense
AccretionExpense
2064000 USD
CY2017Q1 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34970000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46354000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57154000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51453000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
798652000 USD
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
799376000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6319000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7529000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
616000 USD
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
393000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3471000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4101000 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2016Q4 us-gaap Assets
Assets
1807954000 USD
CY2017Q1 us-gaap Assets
Assets
2049015000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
495170000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
568919000 USD
CY2017Q1 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
11300000 USD
CY2016Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.06
CY2017Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.10
CY2016Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
4275000 USD
CY2017Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
7824000 USD
CY2016Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
257012000 USD
CY2017Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
271464000 USD
CY2016Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
131000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
261000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37046000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48132000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77086000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102055000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124113000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28954000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22058000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000.0 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77666000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78185000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
777000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
782000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24656000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12095000 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
84773000 USD
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
86585000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
214670000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
248677000 USD
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-120000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6812000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8088000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6935000 USD
CY2017Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4757000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
148941000 USD
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
130836000 USD
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18253000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19717000 USD
CY2017Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-22000 USD
CY2017Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
586000 USD
CY2016Q1 us-gaap Derivative Net Hedge Ineffectiveness Gain Loss
DerivativeNetHedgeIneffectivenessGainLoss
0 USD
CY2017Q1 us-gaap Derivative Net Hedge Ineffectiveness Gain Loss
DerivativeNetHedgeIneffectivenessGainLoss
0 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
702000 USD
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1280000 USD
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.105
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.348
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
52762000 USD
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
44751000 USD
CY2016Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-4051000 USD
CY2017Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-6128000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
207158000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
218606000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
48100000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
47700000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
48700000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
48800000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
48900000 USD
CY2016Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-61000 USD
CY2017Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-348000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
510571000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
578229000 USD
CY2017Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1170000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14995000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4745000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1576000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1649000 USD
CY2016Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-300000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12057000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8938000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18440000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
589000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1527000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1251000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8104000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5207000 USD
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-386000 USD
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-5685000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
601000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
321000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1288000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1988000 USD
CY2016Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2017Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2139000 shares
CY2016Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1306000 shares
CY2017Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1226000 shares
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1490000 shares
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
561175000 USD
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
654408000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
6373000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
5131000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127973000 USD
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
143228000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
217263000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
239809000 USD
CY2016Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
50043000 USD
CY2017Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
47548000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39247000 USD
CY2017Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
49033000 USD
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
968287000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
1196524000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1807954000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2049015000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
123601000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
188083000 USD
CY2017Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2200000000.0 USD
CY2017Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1500000000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9952000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
185039000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6730000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-193143000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25030000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28882000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
13419000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
6394000 USD
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22100000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
9959000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11734000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13592000 USD
CY2016Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-7000 USD
CY2017Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-2000 USD
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
11244000 USD
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4064000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1292000 USD
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
347000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1292000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30745000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28855000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-738000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-90000 USD
CY2016Q1 us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
0 USD
CY2017Q1 us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
-9976000 USD
CY2016Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2017Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
193928000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10895000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9191000 USD
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27666000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35477000 USD
CY2017Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
900000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
15000000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
210000000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4165000 USD
CY2017Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1038000 USD
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1167000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
222369000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
229110000 USD
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
160000 USD
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2016Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1875000 USD
CY2017Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
20000000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14451000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15494000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
220443000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
226837000 USD
CY2016Q1 us-gaap Revenues
Revenues
236770000 USD
CY2017Q1 us-gaap Revenues
Revenues
258636000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
236770000 USD
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
258636000 USD
CY2016Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
0 USD
CY2017Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
6250000 USD
CY2016Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
665000000 USD
CY2017Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
848750000 USD
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111975000 USD
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
142497000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3265000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5363000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
186853 shares
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2017Q1 us-gaap Short Term Investments
ShortTermInvestments
11286000 USD
CY2016Q4 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
2900000 shares
CY2016Q4 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
123100000 USD
CY2016Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000.0 USD
CY2017Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
150000000 USD
CY2016Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2017Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
839667000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
852491000 USD
CY2016Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2016 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
41.78
CY2017Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
41.78
CY2016Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
123100000 USD
CY2017Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
123100000 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2946000 shares
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2946000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
123051000 USD
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
123051000 USD
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76466000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78394000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73934000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74765000 shares

Files In Submission

Name View Source Status
0000917520-17-000023-index-headers.html Edgar Link pending
0000917520-17-000023-index.html Edgar Link pending
0000917520-17-000023.txt Edgar Link pending
0000917520-17-000023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iart-20170331.xml Edgar Link completed
iart-20170331.xsd Edgar Link pending
iart-2017033110xq.htm Edgar Link pending
iart-20170331xexx311.htm Edgar Link pending
iart-20170331xexx312.htm Edgar Link pending
iart-20170331xexx321.htm Edgar Link pending
iart-20170331xexx322.htm Edgar Link pending
iart-20170331_cal.xml Edgar Link unprocessable
iart-20170331_def.xml Edgar Link unprocessable
iart-20170331_lab.xml Edgar Link unprocessable
iart-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending